I find it fascinating that you think the pod is “huge in comparison to the cannula that I have on my skin”; from my point of view, while that is clearly true, it is not a relevant comparison. I consider it to be “tiny in comparison to a tubed pump”, while the new model if/when it gets approved, will be even smaller.
Your comments on the Omnipod remote are worth a thought too. You say “So if you forget your remote/lose it/have it nicked/etc, you’re stuffed” but that is a) not true, since it will continue to deliver the programmed basal dose, and b) no different than an MDI-er forgetting/losing/being robbed of her short acting insulin. Your point about not being able to deliver a dose directly from the pod is valid and appears to be one of the most common wish-list items on various Omnipod forums. But then we come back to the throwaway design and I suspect the cost of adding another complex mechanism to the pod itself would wreck the economics of the product completely.
Anyway, its great to see other views on the world; wouldn’t it be a dull place if we all agreed?! At least we have a choice – talking of which I must find out how my funding request is getting on…